3 FDA approval firsts that could be around the corner

Listen to the article
5 min

This audio is auto-generated. Please let us know if you have feedback.

The industry’s final months of 2025 could be action-packed as the FDA renders approval decisions on drugs that would be groundbreaking in their indications. 

For some of pharma’s largest drugmakers, upcoming PDUFA dates could pave the way for new formulations of established…